These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38804608)

  • 1. "Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.
    Koehm K; Rosen JG; Yedinak Gray JL; Tardif J; Thompson E; Park JN
    Subst Use Addctn J; 2024 May; ():29767342241253663. PubMed ID: 38804608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America.
    Rosen JG; Thompson E; Tardif J; Collins AB; Marshall BDL; Park JN
    Harm Reduct J; 2024 Feb; 21(1):40. PubMed ID: 38355641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.
    Tan M; Park C; Goldman J; Biello KB; Buxton J; Hadland SE; Park JN; Sherman SG; Macmadu A; Marshall BDL
    Harm Reduct J; 2024 Feb; 21(1):54. PubMed ID: 38424553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction).
    Dunham K; Hill K; Kazal H; Butner JL; Hull I; Sue K; Li L; Doneski K; Dinges B; Rife-Pennington T; Kung S; Thakarar K
    Subst Use Addctn J; 2024 Jul; 45(3):328-336. PubMed ID: 38747578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming stigma: Community support for overdose prevention sites.
    Grisamore SP; DeMatteo D
    Int J Drug Policy; 2024 May; 127():104415. PubMed ID: 38593517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 8. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
    Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.
    Childs E; Biello KB; Valente PK; Salhaney P; Biancarelli DL; Olson J; Earlywine JJ; Marshall BDL; Bazzi AR
    Int J Drug Policy; 2021 Apr; 90():103080. PubMed ID: 33340947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
    Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
    Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
    McKnight C; Des Jarlais DC
    Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing Sanctioned Safe Consumption Sites in the United States: Five Jurisdictions Moving the Policy Agenda Forward.
    Kennedy-Hendricks A; Bluestein J; Kral AH; Barry CL; Sherman SG
    Psychiatr Serv; 2019 Apr; 70(4):294-301. PubMed ID: 30755131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study.
    Bennett AS; Freeman R; Des Jarlais DC; Aronson ID
    JMIR Form Res; 2020 Dec; 4(12):e22411. PubMed ID: 33355094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
    Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
    Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard.
    Waye KM; Yedinak JL; Koziol J; Marshall BDL
    Int J Drug Policy; 2018 Dec; 62():86-93. PubMed ID: 30384027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.
    Collins AB; Macon EC; Levin S; Wunsch C; Wightman RS
    Int J Drug Policy; 2024 May; 127():104391. PubMed ID: 38490014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.